| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.5 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.5 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.5 |